DE69317772D1 - Peptidderivate des Carboxy-Terminalen Sequenz von Hirudin - Google Patents

Peptidderivate des Carboxy-Terminalen Sequenz von Hirudin

Info

Publication number
DE69317772D1
DE69317772D1 DE69317772T DE69317772T DE69317772D1 DE 69317772 D1 DE69317772 D1 DE 69317772D1 DE 69317772 T DE69317772 T DE 69317772T DE 69317772 T DE69317772 T DE 69317772T DE 69317772 D1 DE69317772 D1 DE 69317772D1
Authority
DE
Germany
Prior art keywords
pct
alkyl
hirudin
carboxy
thrombosis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69317772T
Other languages
English (en)
Inventor
Derek Brundish
Hans Rink
Markus Gruetter
John Priestle
Albert Schmitz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
UCP GEN-PHARMA AG ZUERICH CH
UCP Gen Pharma AG
Novartis AG
Original Assignee
UCP GEN-PHARMA AG ZUERICH CH
Ciba Geigy AG
UCP Gen Pharma AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by UCP GEN-PHARMA AG ZUERICH CH, Ciba Geigy AG, UCP Gen Pharma AG filed Critical UCP GEN-PHARMA AG ZUERICH CH
Application granted granted Critical
Publication of DE69317772D1 publication Critical patent/DE69317772D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182—Radicals derived from carboxylic acids
    • C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/34—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D211/62—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/815—Protease inhibitors from leeches, e.g. hirudin, eglin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69317772T 1992-04-25 1993-04-15 Peptidderivate des Carboxy-Terminalen Sequenz von Hirudin Expired - Lifetime DE69317772D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929209032A GB9209032D0 (en) 1992-04-25 1992-04-25 New peptide derivatives
PCT/EP1993/000908 WO1993022344A1 (en) 1992-04-25 1993-04-15 Peptide derivatives corresponding to the carboxy terminal sequence of hirudin

Publications (1)

Publication Number Publication Date
DE69317772D1 true DE69317772D1 (de) 1998-05-07

Family

ID=10714598

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69317772T Expired - Lifetime DE69317772D1 (de) 1992-04-25 1993-04-15 Peptidderivate des Carboxy-Terminalen Sequenz von Hirudin

Country Status (14)

Country Link
US (1) US5686564A (de)
EP (1) EP0637318B1 (de)
JP (1) JPH07505896A (de)
KR (1) KR950701342A (de)
AT (1) ATE164595T1 (de)
AU (1) AU674513B2 (de)
CA (1) CA2133581A1 (de)
DE (1) DE69317772D1 (de)
GB (1) GB9209032D0 (de)
IL (1) IL105510A0 (de)
MX (1) MX9302399A (de)
NZ (1) NZ251709A (de)
WO (1) WO1993022344A1 (de)
ZA (1) ZA932876B (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100325972B1 (ko) * 1993-08-09 2002-07-27 바이오메져 인코퍼레이티드 치료성펩타이드유도체
DE69426569T2 (de) * 1993-10-25 2001-05-10 National Research Council Of Canada, Ottawa Bivalente thrombininhibitore
GB9426038D0 (en) 1994-12-22 1995-02-22 Iaf Biochem Int Low molecular weight bicyclic thrombin inhibitors
GB9505538D0 (en) * 1995-03-18 1995-05-03 Ciba Geigy Ag New compounds
GB9506212D0 (en) * 1995-03-27 1995-05-17 Iaf Biochem Int Bifunctional thrombin inhibitors bearing highly truncated fibrinogen recognition exosite binding component
US6057314A (en) * 1995-12-21 2000-05-02 Biochem Pharma Inc. Low molecular weight bicyclic thrombin inhibitors
DE19607239A1 (de) * 1996-02-27 1997-08-28 Behringwerke Ag Pharmazeutische Zusammensetzung, enthaltend Hirudin und Verfahren zu deren Herstellung
ES2500921T3 (es) 2003-04-29 2014-10-01 Sarepta Therapeutics, Inc. Composiciones para potenciar el transporte y la eficacia antisentido de análogos de ácidos nucleicos en células
CA2536918A1 (en) 2003-08-26 2005-03-03 Leland Shapiro Compositions of, and methods for, alpha-1 antitrypsin fc fusion molecules
US20050288246A1 (en) 2004-05-24 2005-12-29 Iversen Patrick L Peptide conjugated, inosine-substituted antisense oligomer compound and method
ATE480561T1 (de) 2004-10-19 2010-09-15 Lonza Ag Verfahren zur festphasen-peptidsynthese
PT1877090E (pt) * 2005-05-06 2014-04-15 Providence Health System Proteína de fusão trimérica de imunoglobulina-ox40 e métodos de utilização
US8067571B2 (en) 2005-07-13 2011-11-29 Avi Biopharma, Inc. Antibacterial antisense oligonucleotide and method
US20100016215A1 (en) 2007-06-29 2010-01-21 Avi Biopharma, Inc. Compound and method for treating myotonic dystrophy
US9161948B2 (en) 2011-05-05 2015-10-20 Sarepta Therapeutics, Inc. Peptide oligonucleotide conjugates
CA2839917A1 (en) * 2011-06-24 2012-12-27 The Regents Of The University Of Colorado, A Body Corporate Compositions, methods and uses for alpha-1 antitrypsin fusion molecules
JP2015504675A (ja) 2012-01-10 2015-02-16 ザ リージェンツ オブ ザ ユニバーシティ オブ コロラド，ア ボディー コーポレイトＴＨＥ ＲＥＧＥＮＴＳ ＯＦ ＴＨＥ ＵＮＩＶＥＲＳＩＴＹ ＯＦ ＣＯＬＯＲＡＤＯ，ａ ｂｏｄｙ ｃｏｒｐｏｒａｔｅ アルファ−１アンチトリプシン融合分子の組成物、方法、及び使用
WO2016196897A1 (en) 2015-06-04 2016-12-08 Sarepta Therapeutics, Inc. Methods and compounds for treatment of lymphocyte-related diseases and conditions
EP3554553B1 (de) 2016-12-19 2022-07-20 Sarepta Therapeutics, Inc. Exon-skipping-oligomerkonjugate für muskeldystrophie

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4117127A (en) * 1974-11-08 1978-09-26 Mitsubishi Chemical Industries Ltd. N2 -Arylsulfonyl-L-argininamides and the pharmaceutically acceptable salts thereof
CA1131621A (en) * 1977-01-19 1982-09-14 Shosuke Okamoto N.sup.2-arylsulfonyl-l-argininamides and the pharmaceutically acceptable salts thereof
US4258192A (en) * 1977-12-16 1981-03-24 Mitsubishi Chemical Industries Limited N2 -Arylsulfonyl-L-argininamides and the pharmaceutically acceptable salts thereof
IE48623B1 (en) * 1978-08-31 1985-03-20 Mitsubishi Chem Ind Alpha-(n-arylsulfonyl-l-argininamides,processes for their preparation and pharmaceutical compositions containing these substances
FR2628429B1 (fr) * 1988-03-08 1990-12-28 Transgene Sa Variants de l'hirudine, leurs utilisations et les procedes pour les obtenir
US5112615A (en) * 1988-08-03 1992-05-12 New England Deaconess Hospital Corporation Soluble hirudin conjugates
JPH04503660A (ja) * 1988-12-05 1992-07-02 バイオジェン インコーポレイテッド 血小板凝集抑制の方法及び組成物
US5196404B1 (en) * 1989-08-18 1996-09-10 Biogen Inc Inhibitors of thrombin
US5118790A (en) * 1990-07-24 1992-06-02 Sri International Analogs of hirudin

Also Published As

Publication number Publication date
US5686564A (en) 1997-11-11
AU674513B2 (en) 1997-01-02
CA2133581A1 (en) 1993-11-11
WO1993022344A1 (en) 1993-11-11
IL105510A0 (en) 1993-08-18
ATE164595T1 (de) 1998-04-15
ZA932876B (en) 1994-10-19
KR950701342A (ko) 1995-03-23
GB9209032D0 (en) 1992-06-10
NZ251709A (en) 1997-01-29
JPH07505896A (ja) 1995-06-29
MX9302399A (es) 1994-05-31
EP0637318A1 (de) 1995-02-08
EP0637318B1 (de) 1998-04-01
AU3953393A (en) 1993-11-29

Similar Documents

Publication Publication Date Title
DE69317772D1 (de) Peptidderivate des Carboxy-Terminalen Sequenz von Hirudin
ES2191412T3 (es) Derivados de aminoacidos que contienen fluor.
RU2000113595A (ru) Производные пиридонкарбоновой кислоты или его соль
DE69613365D1 (de) Ester der 5-aminolevulinsäure als mittel zur photosensibilisierung in der chemotherapie
EP0456152A3 (en) Peptidamides, their process of preparation and the agents containing these peptides as fibrin-thrombin clotting inhibitors
NO933964D0 (no) Nye perhydroisoindolderivater, deres fremstilling samt farmasoeytiske preparater inneholdende forbindelsene
HUP0301330A2 (hu) 2-Aminokarbonil-9H-purin-származékok
ZA894185B (en) Metalloporphyrin derivatives,their preparation,their application in therapy and their use for the preparation of hybrid molecules
KR960007585A (ko) 벤족사졸릴- 및 벤조티아졸릴옥사졸리디논
DE69231252D1 (de) Substituierte Salizylsäure zur Behandlung von Autoimmunkrankheiten
NZ219255A (en) Unsaturated amino acids and pharmaceutical compositions
DE69219901D1 (de) Adenosinderivate, Verfahren zu deren Herstellung und pharmazeutische Mittel
NO976098L (no) Metallkomplekser av polyaminosyrer og deres anvendelse innen avbildning for diagnoseformål
DE69418744D1 (de) Verwendung von Pregnanderivaten zur Behandlung von Tumoren
AU5801590A (en) Process for dyeing keratinous fibres based on monohydroxyindole and 5,6-disubstituted hydroxyindole and composition employed
NO302749B1 (no) Desferrioksamin-B-salter og anvendelse av disse for fremstilling av farmasöytiske sammensetninger
ZA961395B (en) Metal complexes suitable for use in diagnosis and therapy
DE69104220D1 (de) Verfahren zur Herstellung von direktkomprimierten, Cephalosporansäure Derivate enthaltendenTabletten.
DE69313842D1 (de) Teilweise modifizierte und retro-invertierte tetrapeptides analogue von fragmenten des c reaktiven proteins
ES541194A0 (es) Un procedimiento de preparacion de inhibidores de la renina que contienen estatina o sus derivados.
DE59305911D1 (de) Verwendung von Benzotriazinen als PLA2-Inhibitoren und neue Benzotriazine
HUP9902398A2 (hu) Hidroximsavszármazékok alkalmazása autoimmun betegségek elleni gyógyászati készítmények előállítására
MX9603149A (es) Derivados de camptotecina.
MX9605026A (es) Analisis de imagen de diagnostico con complejos de metal.
HUP0000414A2 (hu) Új pentaeritritszármazékok, előállításuk, alkalmazásuk és intermedierjeik

Legal Events

Date Code Title Description
8332 No legal effect for de